Skip to main content
Caplight Logo









BlueWhale Bio

BlueWhale Bio

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://bluewhale.bio/

Last Round

VC Round

Oct 16, 2025

Total Funding Raised

$18M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BlueWhale Bio is a biotechnology company that develops cell-derived nanoparticle platforms to improve the manufacturing efficiency and accessibility of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS

AI Layer

Non-AI

Keywords

cell therapy manufacturingCAR-T manufacturingbioprocessing reagentsbiomanufacturingcell expansioncell activationbiotech supply chaincell therapy toolsCMCchemistry manufacturing and controlsCDNPscell-derived nanoparticlesbiotech scale-upprocess developmentlab-grown therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BlueWhale Bio Comparables

Compare BlueWhale Bio with similar companies based on industry and business-model similarity.

BlueWhale Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sartorius Aktiengesellschaft
77%
Miltenyi Biotec
77%
Thermo Fisher Scientific Inc.
74%

BlueWhale Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 16, 2025
SeedSep 7, 2023

BlueWhale Bio Investors

Notable investors and investment history

BlueWhale Bio investors
InvestorRounds
Hillhouse InvestmentSeed
Danaher VenturesSeed
Novalis LifeSciencesSeed
Marshall WaceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 17, 2026

    Grew 17% QoQ, from 30 to 35 employees.

  • Apr 4, 2026

    Monthly visitors increased 43% MoM.

BlueWhale Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BlueWhale Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BlueWhale Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range35
Year Founded2023
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?